DK314180A - Fremgangsmaade til fremstilling af 3-(hydroxy eller hydroxymethyl)-5-(-pyridinyl)-2(1h)-pyridionen eller syreadditionssalte deraf - Google Patents

Fremgangsmaade til fremstilling af 3-(hydroxy eller hydroxymethyl)-5-(-pyridinyl)-2(1h)-pyridionen eller syreadditionssalte deraf

Info

Publication number
DK314180A
DK314180A DK314180A DK314180A DK314180A DK 314180 A DK314180 A DK 314180A DK 314180 A DK314180 A DK 314180A DK 314180 A DK314180 A DK 314180A DK 314180 A DK314180 A DK 314180A
Authority
DK
Denmark
Prior art keywords
pyridion
pyridinyl
hydroxymethyl
hydroxy
preparing
Prior art date
Application number
DK314180A
Other languages
English (en)
Inventor
G Y Lesher
C J Opalka
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of DK314180A publication Critical patent/DK314180A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK314180A 1979-09-10 1980-07-22 Fremgangsmaade til fremstilling af 3-(hydroxy eller hydroxymethyl)-5-(-pyridinyl)-2(1h)-pyridionen eller syreadditionssalte deraf DK314180A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/073,885 US4225601A (en) 1979-09-10 1979-09-10 3-Hydroxy or hydroxymethyl-5-(4-pyridinyl)2(1H)-pyridinones, useful as cardiotonic agents and their preparation

Publications (1)

Publication Number Publication Date
DK314180A true DK314180A (da) 1981-03-11

Family

ID=22116385

Family Applications (1)

Application Number Title Priority Date Filing Date
DK314180A DK314180A (da) 1979-09-10 1980-07-22 Fremgangsmaade til fremstilling af 3-(hydroxy eller hydroxymethyl)-5-(-pyridinyl)-2(1h)-pyridionen eller syreadditionssalte deraf

Country Status (21)

Country Link
US (1) US4225601A (da)
JP (1) JPS5668670A (da)
KR (1) KR830003470A (da)
AR (1) AR223716A1 (da)
AU (1) AU6003080A (da)
BE (1) BE884329A (da)
DE (1) DE3027901A1 (da)
DK (1) DK314180A (da)
ES (1) ES8106514A1 (da)
FI (1) FI802298A (da)
FR (1) FR2465722A1 (da)
GB (1) GB2058751A (da)
IL (1) IL60360A0 (da)
IT (1) IT1132192B (da)
LU (1) LU82650A1 (da)
NL (1) NL8004126A (da)
NO (1) NO802138L (da)
NZ (1) NZ194106A (da)
PT (1) PT71427A (da)
SE (1) SE8004934L (da)
ZA (1) ZA803679B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361569A (en) * 1981-08-26 1982-11-30 Sterling Drug Inc. 3-(Hydroxy or hydroxymethyl)-6-methyl-5-(4-pyridinyl)-2(1H)-pyridinone and cardiotonic use thereof
US4432979A (en) * 1981-10-26 1984-02-21 William H. Rorer, Inc. Pyridone compounds
US4463008A (en) * 1982-11-10 1984-07-31 Sterling Drug Inc. 2-Alkoxy-5-(pyridinyl)pyridines and cardiotonic use thereof
US6068581A (en) * 1998-04-29 2000-05-30 Timm Medical Technologies, Inc. Method and apparatus for testing and exercising pelvic muscles
CN102933079B (zh) * 2010-03-04 2016-02-17 默沙东公司 儿茶酚-o-甲基转移酶抑制剂及其在治疗精神障碍中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
NL8004126A (nl) 1981-03-12
DE3027901A1 (de) 1981-03-26
FR2465722A1 (fr) 1981-03-27
LU82650A1 (fr) 1981-03-24
ZA803679B (en) 1981-06-24
ES493583A0 (es) 1981-07-01
US4225601A (en) 1980-09-30
IT8023422A0 (it) 1980-07-14
ES8106514A1 (es) 1981-07-01
FI802298A (fi) 1981-03-11
BE884329A (fr) 1981-01-16
IL60360A0 (en) 1980-09-16
SE8004934L (sv) 1981-03-11
AR223716A1 (es) 1981-09-15
JPS5668670A (en) 1981-06-09
PT71427A (en) 1980-07-01
AU6003080A (en) 1981-03-19
NZ194106A (en) 1982-03-30
IT1132192B (it) 1986-06-25
GB2058751A (en) 1981-04-15
KR830003470A (ko) 1983-06-20
NO802138L (no) 1981-03-11

Similar Documents

Publication Publication Date Title
DK481879A (da) Fremgangsmaade til fremstilling af 5-(2-imidazolin-2-yl)-aminopyrimidiner eller syreadditionssalte deraf
DK145260C (da) Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf
DK536480A (da) Fremgangsmaade til fremtlling af isoquinolineddikesyre-forbindelser eller salte deraf
DK294780A (da) Fremgangsmaade til fremstilling af trans-3-(4-oxo4h-quinazolin-3-yl)-2-propensyrederivater eller salte deraf
DK323780A (da) Fremgangsmaade til fremstilling af substituerede 3-amino-sydnonimider eller farmakologisk acceptable syreadditionssalte deraf
DK453181A (da) Fremgangsmaade til fremstilling af 2-quanidino-4-heteroaryl-thiazolforbindelser eller syreadditionssalte deraf
DK413783A (da) Fremgangsmaade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf
DK334581A (da) Fremgangsmaade til frmstilling af 9-amino-1-hydroxyotahydro-6h-benzo (c) quinolin-derivater eller syreadditionssalte deraf
DK405981A (da) Fremgangsmaade til fremstilling af n-oxider af n-oxacyclylalkylpiperidyl-diazaforbindelser eller syreadditionssalte deraf
DK287380A (da) Fremgangsmaade til fremstilling af 2-phenyl-2-hydroxy-1-(1-imidazolyl)alkan- eller- alkenforbindelser eller syreadditionssalte deraf
DK144944C (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
DK160616C (da) Fremgangsmaade til fremstilling af anthracyclinderivater eller syreadditionssalte deraf
DK99980A (da) Fremgangsmaade til fremstilling af mercaptoacyldihydropyrazolcarboxylsyrederivater
DK495780A (da) Fremgangsmaade til fremstilling af 2-keto-l-gulonsyre eller salte deraf
DK314180A (da) Fremgangsmaade til fremstilling af 3-(hydroxy eller hydroxymethyl)-5-(-pyridinyl)-2(1h)-pyridionen eller syreadditionssalte deraf
DK162448C (da) Fremgangsmaade til fremstilling af 17beta-hydroxy-3-oxo-17alfa-pregn-4-en-21-carboxylsyre delta-lacton eller 17beta-hydroxy-3-oxo-17alfa-pregna-4,6-dien-21-carboxylsyre delta-lacton
DK365980A (da) Fremgangsmaade til fremstilling af 7-betaaminothiadiazolylacetylamino-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK403080A (da) Fremgangsmaade til fremstilling af 4-thioalkylpyridin- eller -pyrimidin-forbindelser eller syreadditionssalte deraf
DK152672C (da) Fremgangsmaade til fremstilling af 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-t-butylaminoethyl)pyridin eller syreadditionssalte heraf
DK351880A (da) Fremgangsmaade til fremstilling af tetrahydroquinoliner eller syreadditionssalte deraf
DK211381A (da) Fremgangsmaade til fremstilling af carbapenam3-carboxylsyre- eller carbapen-2-em-3-carboxylsyre-forbindelser eller estere eller salte deraf
DK300080A (da) Fremgangsmaade til fremstilling af ergol-8-en-eller ergolinforbindelser eller syreadditionsalte deraf
DK455980A (da) Analogifremgangsmaade til fremstilling af spiroimidazolonforbindelser eller syreaddiionssalte deraf
DK152501C (da) Fremgangsmaade til fremstilling af pyrrolooe1,2-aaapyrimidiner eller salte deraf
DK550480A (da) Fremgangsmaade til fremstilling af 3-acylamino-5-(pyridinyl)-2(1h)-pyridinoner